312 related articles for article (PubMed ID: 26248883)
1. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
[TBL] [Abstract][Full Text] [Related]
2. Consistency of heart rate-QTc prolongation consistency and sudden cardiac death: The Rotterdam Study.
Niemeijer MN; van den Berg ME; Deckers JW; Franco OH; Hofman A; Kors JA; Stricker BH; Rijnbeek PR; Eijgelsheim M
Heart Rhythm; 2015 Oct; 12(10):2078-85. PubMed ID: 26165945
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for QTc interval prolongation.
Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
[TBL] [Abstract][Full Text] [Related]
5. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
6. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study.
Iribarren C; Round AD; Peng JA; Lu M; Zaroff JG; Holve TJ; Prasad A; Stang P
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1222-32. PubMed ID: 23857878
[TBL] [Abstract][Full Text] [Related]
7. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart.
Tabo M; Komatsu R; Isobe T; Honda M; Yamada Y; Kimura K
J Toxicol Sci; 2010 Oct; 35(5):687-98. PubMed ID: 20930463
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and determinants of QT interval prolongation in medical inpatients.
Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
[TBL] [Abstract][Full Text] [Related]
9. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.
Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227
[TBL] [Abstract][Full Text] [Related]
10. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
11. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
Corović N; Duraković Z; Misigoj-Duraković M
Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
[TBL] [Abstract][Full Text] [Related]
12. Ventricular repolarization in diabetic patients: characterization and clinical implications.
Clemente D; Pereira T; Ribeiro S
Arq Bras Cardiol; 2012 Nov; 99(5):1015-22. PubMed ID: 23108644
[TBL] [Abstract][Full Text] [Related]
13. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.
Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E
Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202
[TBL] [Abstract][Full Text] [Related]
14. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
15. QTC TENDENCY IN PACEMAKER DEPENDENT PATIENTS - PROGNOSTIC MEANING OF LONG QTC DURING 5 YEAR FOLLOW UP.
Tsetskhladze E; Khintibidze I
Georgian Med News; 2016 Apr; (253):56-60. PubMed ID: 27249436
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcomes of long QTc in acute medical admissions.
Mahmud R; Gray A; Nabeebaccus A; Whyte MB
Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
[TBL] [Abstract][Full Text] [Related]
18. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
19. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.
Lazzerini PE; Cevenini G; Qu YS; Fabris F; El-Sherif N; Acampa M; Cartocci A; Laghi-Pasini F; Capecchi PL; Boutjdir M; Lazaro D
J Am Heart Assoc; 2021 Feb; 10(4):e018735. PubMed ID: 33533258
[TBL] [Abstract][Full Text] [Related]
20. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]